Risk factors for cerebral degenerative changes and dementia

被引:24
作者
Meyer, JS [1 ]
Terayama, Y [1 ]
Konno, S [1 ]
Akiyama, H [1 ]
Margishvili, GM [1 ]
Mortel, KF [1 ]
机构
[1] Baylor Coll Med, VA Med Ctr, Cerebrovasc Res Labs, Dept Neurol, Houston, TX 77030 USA
关键词
normal human aging; risk factors; cognitive decline; dementia; longitudinal analysis; cerebral atrophy and degenerative change; neuroimaging;
D O I
10.1159/000052064
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
It is concluded that the most important determinants for cerebral neurodegenerative changes and cognitive decline during aging are neuronal shrinkage and/or loss, which are accelerated by certain risk factors: e.g. TIAs, hypertension, heart disease, hyperlipidemia, smoking, heavy alcohol consumption, male gender, low educational status, family history of cerebrovascular disease and absence of estrogen replacement therapy among women. Some of these risk factors are remediable by therapeutic interventions, including prevention of TIAs and medications that control hypertension, heart disease, hyperlipidemia and estrogen replacement in postmenopausal women, as well as abstention from abuse of tobacco and alcohol. Cerebral neurodegenerative changes measured by neuroimaging appear to be premorbid markers for depleted neuronal and synaptic reserves which predispose to the onset of dementias of both VAD and DAT types. Normal subjects at risk for cognitive decline include those with TIAs, hypertension and heart disease since these risk factors measurably accelerate cerebral atrophy, ventricular enlargement, leukoaraiosis, and decline in cortical perfusion.
引用
收藏
页码:7 / 16
页数:10
相关论文
共 53 条
[21]  
KETY S S, 1956, J Chronic Dis, V3, P478, DOI 10.1016/0021-9681(56)90146-1
[22]  
KETY SS, 1951, PHARMACOL REV, V3, P1
[23]  
KOBARI M, 1990, AM J NEURORADIOL, V11, P273
[24]   CLINICAL RISK-FACTORS FOR ALZHEIMERS-DISEASE - A POPULATION-BASED CASE-CONTROL STUDY [J].
KOKMEN, E ;
BEARD, CM ;
CHANDRA, V ;
OFFORD, KP ;
SCHOENBERG, BS ;
BALLARD, DJ .
NEUROLOGY, 1991, 41 (09) :1393-1397
[25]   LOW BLOOD-PRESSURE AND BLOOD-GLUCOSE LEVELS IN ALZHEIMERS-DISEASE - EVIDENCE FOR A HYPOMETABOLIC DISORDER [J].
LANDIN, K ;
BLENNOW, K ;
WALLIN, A ;
GOTTFRIES, CG .
JOURNAL OF INTERNAL MEDICINE, 1993, 233 (04) :357-363
[26]   Vascular dementia: Still a debatable entity? [J].
Loeb, C ;
Meyer, JS .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 143 (1-2) :31-40
[27]   DECREASES IN REGIONAL CEREBRAL BLOOD-FLOW WITH NORMAL AGING [J].
MARTIN, AJ ;
FRISTON, KJ ;
COLEBATCH, JG ;
FRACKOWIAK, RSJ .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1991, 11 (04) :684-689
[28]   QUANTITATIVE SYNAPTIC ALTERATIONS IN THE HUMAN NEOCORTEX DURING NORMAL AGING [J].
MASLIAH, E ;
MALLORY, M ;
HANSEN, L ;
DETERESA, R ;
TERRY, RD .
NEUROLOGY, 1993, 43 (01) :192-197
[29]   PROSPECTIVE CT CONFIRMS DIFFERENCES BETWEEN VASCULAR AND ALZHEIMERS DEMENTIA [J].
MEYER, JS ;
MURAMATSU, K ;
MORTEL, KF ;
OBARA, K ;
SHIRAI, T .
STROKE, 1995, 26 (05) :735-742
[30]   CEREBRAL ATROPHY AND HYPOPERFUSION IMPROVE DURING TREATMENT OF WERNICKE-KORSAKOFF SYNDROME [J].
MEYER, JS ;
TANAHASHI, N ;
ISHIKAWA, Y ;
HATA, T ;
VELEZ, M ;
FANN, WE ;
KANDULA, P ;
MORTEL, KF ;
ROGERS, RL .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1985, 5 (03) :376-385